Evaluation of the Bedside Glucose Monitoring System in Neonatal Units
WICHULADA KIATTIMONGKOL, MD*, ARUCHALEAN WATANACHAI, BSc**, CHITTIWAT SUPRASONGSIN, MD**
Affiliation : *Pediatric Unit, Maharat Nakhon Ratchasima Hospital, Nakhon Ratchasima 30000, **Research Center, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand. ® Medisafe Reader [Terumo (Thailand) Co., Ltd.]
Objective : To evaluate the performance of a commercial® reader compared with a laboratory method in neonates with a variety of diseases and conditions.
Patients and
Method : A total of 175 patients were included in the present study. Venous whole blood samples were analyzed with a commercial® reader by trained nurse. Through the same sampling site, specimens were collected, spun and plasma were sent to the laboratory for measurement of plasma glucose.
Results : The regression analysis between the results of a commercial® reader and laboratory = glucose were significantly correlated (r 0.97; p < 0.001) with the result as follows: A commercial® reader = Laboratory glucose -0.17 (n = 175). A positive slope of 0.04 was found between hematocrit and difference between a commercial® reader and laboratory plasma glucose. However, this correlation was of little clinical significance.
Conclusions : A commercial® reader showed a good correlation with the standard laboratory method for the measurement of plasma glucose in neonates with a variety of diseases and conditions.
Keywords : A Commercial® Reader, Neonatal, Blood Glucose, Hypoglycemia, Hyperglycemia
